Understanding of psychiatric disorders is catching up to a reality all too familiar to the doctors who treat patients: one-size-fits-all treatments for complex conditions like depression or bipolar disorder are coming up short.
Why it matters: As new treatments hit the market, researchers are still trying to understand the underpinnings of the disorders in hopes of tailoring medicines to those patients who will benefit most.
Sen. Ed Markey (D-Mass.) wants increased transparency around private equity investment in health care services companies, such as hospitals, dialysis centers, and physician groups.
Zoom in: He also is proposing new federal abilities to stop those deals from ever happening.
After losing out on the COVID-19 vaccine race, Novavax is hoping its experimental combo flu-COVID vaccine can help turn around its fortunes.
But it finds itself in a familiar position of playing catch-up.
Why it matters: A year after it warned about its ability to remain in business, the Maryland company is trailing Pfizer-BioNTech and Moderna in the development of a combination product that would reduce the need for multiple shots during respiratory virus season.
Former President Trump's surgeon general is advocating for conservative states to back needle exchanges as a strategy to reduce transmission of infectious diseases like HIV and hepatitis C and save lives while the fentanyl epidemic rages on.
Why it matters: Making illicit drug use easier may seem counterintuitive, but it's been shown to improve public health and reduce societal costs, Jerome Adams argued in an opinion piece he co-authored in USA Today.
Tensions between hospitals and Medicare Advantage insurers are poised to keep growing as the program gets larger and the federal government takes a harder line on health plans.
Why it matters: How hospitals and insurers respond to financial threats could ultimately affect the care received by more than half of seniors now enrolled in the program — whether it means reduced benefits, fewer provider choices or higher costs.
Gympass is rebranding to Wellhub, the health-focused startup announced Thursday.
Why it matters: Valued at $2.4 billion as of last summer, the company is "pursuing a much bigger market," co-founder and CEO Cesar Carvalho tells Axios.
1 in 3 LGBT adultssay a health care provider has disrespected or treated them unfairly, twice the rate of adults who don't identify as LGBT, according to a new KFF survey.
Why it matters: These negative interactions with the health care system are also leading to worse health care outcomes, the survey finds.
Autism Impact Fund, a venture capital group focused on autism and other neurodevelopmental disorders, has closed its debut fund with $60 million.
Why it matters: 1 in 36 kids in the U.S. has autism, up from the prior rate of 1 in 44, according to the CDC. But treatments lag far behind the rampancy.
The Senate homeland security committee is examining whether expanding private equity control over hospital emergency departments is compromising patient care and potentially putting emergency preparedness at risk.
Why it matters: A new inquiry by Chairman Gary Peters (D-Mich.) adds to congressional scrutiny of big private equity firms' ownership of hospitals, physician staffing firms, nursing homes and other cogs in the health system.
